ClinicalTrials.govpublic full text
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, myelodysplastic syndromes, accelerated phase chronic myelogenous leukemia, chronic phase chronic myelogenous leukemia, relapsing chronic myelogenous leukemia, childhood chronic myelogenous leukemia, previously treated myelodysplastic syndromes, recurrent adult acute lymphoblastic leukemia, recurrent childhood acute lymphoblastic leukemia, adult acute myeloid leukemia with 11q23 (mll) abnormalities
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 829448
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.